MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)

May 29, 2019 admin CEO Interview, Healthcare Comments Off on MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

Roby Zomer, CEO

 

 

 

 

 

 

 

MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) CEO Interview with Roby Zomer, discussing the company’s vertically integrated “Seed-to Pharmacy” strategy, and product pipeline. The company has three products in the pipeline, targeting: drug-resistant epliepsy, dementia, and Chron’s disease/Irritable Bowel Disease (IBS).

MGC Pharmaceuticals has recently started generating revenues from sales of CannEpil, for treating drug-resistant epilepsy in Australia and UK via the “authorised prescriber” program, prior to final regulatory approval, expected in 3-4 years. The immediately addressable market opportunity is potentially 700,000 patients at $9,000 per year.

Other topics discussed in this interview include: Overview of European manufacturing and distribution operations, and more.

 

Investor Presentation

Mgc pharma




Related Articles

Newsmakers

Medicine Man Technologies (OTC: MDCL) Highlights Landmark Consolidation Strategy To Create One Of North America’s Largest Vertically Integrated Cannabis Operators. Projected Annual Revenues From The Previously Disclosed Proposed Acquisitions Total Approximately $170 Million In 2019

September 16, 2019 admin Newsmakers Comments Off on Medicine Man Technologies (OTC: MDCL) Highlights Landmark Consolidation Strategy To Create One Of North America’s Largest Vertically Integrated Cannabis Operators. Projected Annual Revenues From The Previously Disclosed Proposed Acquisitions Total Approximately $170 Million In 2019

DENVER, Sept. 16, 2019 — Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man Technologies” or the “Company”) announced a culmination of its roll-up strategy today that would solidify the Company as one of the largest vertically integrated cannabis […]

Newsmakers

The Green Organic Dutchman (TSX: TGOD) Completes Initial Public Offering and Commences Trading on the Toronto Stock Exchange

May 2, 2018 admin Newsmakers Comments Off on The Green Organic Dutchman (TSX: TGOD) Completes Initial Public Offering and Commences Trading on the Toronto Stock Exchange

TORONTO, May 02, 2018 — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) is pleased to announce that it has successfully completed an initial public offering (the “Offering”) of 31,510,000 units (the “Units”) […]